• LINC01977 Super-Enhancer Hijacking in Early LUAD

  2026-09-23

  Zhang et al. describe a reciprocal circuit in which tumor-associated macrophage-associated TGF-β signaling activates the LINC01977 super-enhancer, while LINC01977 promotes SMAD3-dependent transcription and malignant behavior in lung adenocarcinoma. The findings connect enhancer regulation, immune context, and transcriptional coactivation, while suggesting experiments to test this pathway rather than establishing a treatment strategy.

• Deoxycholic Acid Sodium Salt in Adipose Research

  2026-09-23

  Deoxycholic acid sodium salt is an amphiphilic bile-salt detergent with utility in membrane and protein workflows. The cited adipose study supports Netrin-1, PPARγ, and Wnt/β-catenin as biological benchmarks, but it does not establish sodium deoxycholate as a direct regulator of that pathway.

• 5-Methyl-CTP for Stable mRNA Workflows

  2026-09-22

  5-Methyl-CTP helps researchers engineer IVT-derived mRNA for greater stability and translation performance. This practical guide connects nucleotide substitution, quality control, and formulation-ready assay design with lessons from an H5N1 mRNA vaccine study in lactating dairy cows.

• Iptacopan Monotherapy in PNH: Study Insights

  2026-09-22

  This phase 2 proof-of-concept study found that oral Iptacopan (LNP023) monotherapy rapidly reduced hemolysis and improved hemoglobin and transfusion outcomes in treatment-naive patients with paroxysmal nocturnal hemoglobinuria. Its main innovation was to test proximal alternative-pathway inhibition as a single-agent strategy rather than only as add-on treatment to terminal complement blockade.

• METTL9–PRA1 Antifungal Defense in the Gut

  2026-09-21

  Bao et al. identify secreted METTL9 as a catalytic mucosal defense factor that methylates the Candida albicans zincophore PRA1, disrupting fungal zinc acquisition and limiting intestinal colonization. The study connects epithelial antifungal secretion with multidrug-resistant Candida auris and inflammatory bowel disease, while offering a mechanistically distinct framework for interpreting antifungal susceptibility and host–fungus interactions.

• Fluconazole and the Next Era of Resistance Research

  2026-09-21

  Fluconazole is more than a benchmark antifungal compound. By pairing its defined action as a fungal cytochrome P450 enzyme 14α-demethylase inhibitor with PP2A–ATG pathway analysis, researchers can connect ergosterol disruption to biofilm adaptation, autophagy, and antifungal drug resistance research.

• PPT and the ERα–FOXM1 Translational Axis

  2026-09-20

  PPT offers a selective pharmacological lever for separating ERα biology from ERβ activity and testing whether estrogen receptor signaling contributes causally to FOXM1-linked biology in female lung adenocarcinoma. This article connects receptor pharmacology, biomarker validation, experimental design, and translational decision-making without treating association as proof of mechanism.

• Parathyroid hormone (1-34) (human) in CKD

  2026-09-19

  Use Parathyroid hormone (1-34) (human) as a defined receptor agonist to connect cAMP signaling with endothelial-to-mesenchymal transition, valve calcification, and bone remodeling workflows. This guide translates the Foxp1–Notch findings in CKD research into practical assay design, controls, dosing choices, and troubleshooting strategies.

• BRCA2-Dependent Nascent Strand Maturation Under Olaparib

  2026-09-18

  The 2026 Molecular Cell study identifies a BRCA2- and RAD51-associated pathway that matures nascent DNA strands and repairs olaparib-induced gaps during replication. Its findings broaden the mechanistic basis of PARP inhibitor sensitivity beyond fork reversal, linking LIG1 dysfunction, replication-associated PARP activity, and BRCA-dependent gap repair.

• Sulforaphane: From Redox Signals to Assay Design

  2026-09-18

  Sulforaphane research connects Keap1–Nrf2 signaling with cell-cycle control, apoptosis, and inflammatory redox biology. This guide translates those mechanisms into an integrated assay strategy grounded in recent colitis findings and practical C4733 handling considerations.

• Monomethyl auristatin E: Assay Workflows

  2026-09-17

  Monomethyl auristatin E (MMAE) is a high-potency tubulin polymerization inhibitor that supports both free-payload benchmarking and antibody-drug conjugate development. This practical guide connects MMAE cytotoxicity workflows with the reference study’s findings on EBV-driven plasticity in nasopharyngeal carcinoma, while clearly separating established evidence from proposed assay extensions.

• Schizophrenia Risk Pathways in Developing Neurons

  2026-09-17

  Liu et al. show that schizophrenia-associated GWAS loci converge on different biological pathways in developing cortical interneurons and glutamatergic neurons. Their combination of iPSC-derived neuronal models, epigenomic profiling, structural analysis, and electrophysiology links interneuron risk to PKC hyperactivity and glutamatergic-neuron risk to ion-transport dysfunction.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-09-16

  The 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic requirement for primary cilia formation, neural progenitor survival, and normal brain development. By combining a mouse model with human induced pluripotent stem cell systems, the researchers connect SMPD4 deficiency to cerebellar hypoplasia, shortened cilia, and neural cell death, while showing that exogenous ceramide can rescue the cilia phenotype.

• HRP Rabbit Anti-Goat IgG (H+L) Guide

  2026-09-16

  The HRP Rabbit Anti-Goat IgG (H+L) Antibody is a horseradish peroxidase conjugated secondary antibody for immunodetection of goat primary antibodies. Its affinity-purified, heavy-and-light-chain format supports sensitive ELISA, western blot, dot blot, and tissue-staining workflows when the primary antibody host and assay controls are appropriate.

• METTL9 and Catalytic Antifungal Mucosal Defense

  2026-09-15

  The reference study identifies secreted METTL9 as a catalytic intestinal defense factor that methylates the Candida albicans zincophore PRA1, disrupting fungal zinc acquisition. Its findings connect epithelial secretion, nutrient restriction, fungal colonization, dissemination, and inflammatory bowel disease-associated loss of mucosal antifungal control.

8405 records 1/561 page Next 12345 下5页 Last page